
A Game Changer in Medicine
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
-
Narrado por:
-
De:
Acerca de esta escucha
Life-saving therapies beyond diabetes
A class of drugs called glucagon-like peptide agonists (GLP-1 agonists) is proving to be beneficial for people with chronic kidney disease and atherosclerotic heart disease. These medications are being called game changers because they not only help with weight loss but also provide organ protection and reduce the risk of dying and disease progression.
These medications have the potential to revolutionize the treatment of deadly conditions and improve population health. However, there are financial pressures and healthcare policies that may hinder access to these medications for patients who could benefit from them.
On today's program, host Sean Collins talks with two Physician-Researchers working on the front lines of the coming change.